These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
305 related articles for article (PubMed ID: 17601433)
1. Bevacizumab (Avastin) for diabetic macular edema in previously vitrectomized eyes. Yanyali A; Aytug B; Horozoglu F; Nohutcu AF Am J Ophthalmol; 2007 Jul; 144(1):124-6. PubMed ID: 17601433 [TBL] [Abstract][Full Text] [Related]
2. Long-term effect of intravitreal bevacizumab (avastin) in patients with chronic diffuse diabetic macular edema. Kook D; Wolf A; Kreutzer T; Neubauer A; Strauss R; Ulbig M; Kampik A; Haritoglou C Retina; 2008 Oct; 28(8):1053-60. PubMed ID: 18779710 [TBL] [Abstract][Full Text] [Related]
3. Intravitreal bevacizumab (Avastin) therapy for persistent diffuse diabetic macular edema. Haritoglou C; Kook D; Neubauer A; Wolf A; Priglinger S; Strauss R; Gandorfer A; Ulbig M; Kampik A Retina; 2006; 26(9):999-1005. PubMed ID: 17151486 [TBL] [Abstract][Full Text] [Related]
4. Effects of macular ischemia on the outcome of intravitreal bevacizumab therapy for diabetic macular edema. Chung EJ; Roh MI; Kwon OW; Koh HJ Retina; 2008; 28(7):957-63. PubMed ID: 18698297 [TBL] [Abstract][Full Text] [Related]
5. Analysis of the effect of intravitreal bevacizumab injection on diabetic macular edema after cataract surgery. Takamura Y; Kubo E; Akagi Y Ophthalmology; 2009 Jun; 116(6):1151-7. PubMed ID: 19376589 [TBL] [Abstract][Full Text] [Related]
6. Primary intravitreal bevacizumab (Avastin) for diabetic macular edema: results from the Pan-American Collaborative Retina Study Group at 6-month follow-up. Arevalo JF; Fromow-Guerra J; Quiroz-Mercado H; Sanchez JG; Wu L; Maia M; Berrocal MH; Solis-Vivanco A; Farah ME; Ophthalmology; 2007 Apr; 114(4):743-50. PubMed ID: 17398322 [TBL] [Abstract][Full Text] [Related]
7. Comparative therapy evaluation of intravitreal bevacizumab and triamcinolone acetonide on persistent diffuse diabetic macular edema. Shimura M; Nakazawa T; Yasuda K; Shiono T; Iida T; Sakamoto T; Nishida K Am J Ophthalmol; 2008 May; 145(5):854-61. PubMed ID: 18328456 [TBL] [Abstract][Full Text] [Related]
8. Effect of intravitreal bevacizumab based on optical coherence tomography patterns of diabetic macular edema. Kim M; Lee P; Kim Y; Yu SY; Kwak HW Ophthalmologica; 2011; 226(3):138-44. PubMed ID: 21822008 [TBL] [Abstract][Full Text] [Related]
9. Primary intravitreal bevacizumab for diffuse diabetic macular edema: the Pan-American Collaborative Retina Study Group at 24 months. Arevalo JF; Sanchez JG; Wu L; Maia M; Alezzandrini AA; Brito M; Bonafonte S; Lujan S; Diaz-Llopis M; Restrepo N; RodrÃguez FJ; Udaondo-Mirete P; Ophthalmology; 2009 Aug; 116(8):1488-97, 1497.e1. PubMed ID: 19545900 [TBL] [Abstract][Full Text] [Related]
10. [Combined pharmacosurgery as treatment for diabetic macular edema: core pars plana vitrectomy and intravitreal injection of bevacizumab and triamcinolone]. Naser H; Koss MJ; Singh P; Koch F Klin Monbl Augenheilkd; 2011 Oct; 228(10):910-4. PubMed ID: 21997827 [TBL] [Abstract][Full Text] [Related]
11. Intravitreal bevacizumab for refractory pseudophakic cystoid macular edema: the Pan-American Collaborative Retina Study Group results. Arevalo JF; Maia M; Garcia-Amaris RA; Roca JA; Sanchez JG; Berrocal MH; Wu L; Ophthalmology; 2009 Aug; 116(8):1481-7, 1487.e1. PubMed ID: 19545901 [TBL] [Abstract][Full Text] [Related]
12. Features of optical coherence tomography are predictive of visual outcomes after intravitreal bevacizumab injection for diabetic macular edema. Roh MI; Kim JH; Kwon OW Ophthalmologica; 2010; 224(6):374-80. PubMed ID: 20453545 [TBL] [Abstract][Full Text] [Related]
13. Intravitreal bevacizumab vs intravitreal triamcinolone combined with macular laser grid for diffuse diabetic macular oedema. Forte R; Cennamo GL; Finelli M; Farese E; D'Amico G; Nicoletti G; de Crecchio G; Cennamo G Eye (Lond); 2010 Aug; 24(8):1325-30. PubMed ID: 20300127 [TBL] [Abstract][Full Text] [Related]
14. Randomized trial of intravitreal bevacizumab alone or combined with triamcinolone versus macular photocoagulation in diabetic macular edema. Soheilian M; Ramezani A; Obudi A; Bijanzadeh B; Salehipour M; Yaseri M; Ahmadieh H; Dehghan MH; Azarmina M; Moradian S; Peyman GA Ophthalmology; 2009 Jun; 116(6):1142-50. PubMed ID: 19376585 [TBL] [Abstract][Full Text] [Related]
15. Intravitreal bevacizumab for diabetic macular edema associated with severe capillary loss: one-year results of a pilot study. Bonini-Filho M; Costa RA; Calucci D; Jorge R; Melo LA; Scott IU Am J Ophthalmol; 2009 Jun; 147(6):1022-30, 1030.e1-5. PubMed ID: 19327746 [TBL] [Abstract][Full Text] [Related]
16. Primary intravitreal bevacizumab for the management of pseudophakic cystoid macular edema: pilot study of the Pan-American Collaborative Retina Study Group. Arevalo JF; Garcia-Amaris RA; Roca JA; Sanchez JG; Wu L; Berrocal MH; Maia M; J Cataract Refract Surg; 2007 Dec; 33(12):2098-105. PubMed ID: 18053911 [TBL] [Abstract][Full Text] [Related]
17. Intravitreal bevacizumab (avastin) injection alone or combined with triamcinolone versus macular photocoagulation as primary treatment of diabetic macular edema. Soheilian M; Ramezani A; Bijanzadeh B; Yaseri M; Ahmadieh H; Dehghan MH; Azarmina M; Moradian S; Tabatabaei H; Peyman GA Retina; 2007; 27(9):1187-95. PubMed ID: 18046223 [TBL] [Abstract][Full Text] [Related]
18. Comparison of intravitreal bevacizumab and ranibizumab treatment for diabetic macular edema. Ozturk BT; Kerimoglu H; Bozkurt B; Okudan S J Ocul Pharmacol Ther; 2011 Aug; 27(4):373-7. PubMed ID: 21631366 [TBL] [Abstract][Full Text] [Related]
19. Intravitreal bevacizumab for the treatment of refractory diabetic macular edema. Mehta S; Blinder KJ; Shah GK; Kymes SM; Schlief SL; Grand MG Ophthalmic Surg Lasers Imaging; 2010; 41(3):323-9. PubMed ID: 20507016 [TBL] [Abstract][Full Text] [Related]
20. Correlation of fundus autofluorescence with spectral-domain optical coherence tomography and vision in diabetic macular edema. Chung H; Park B; Shin HJ; Kim HC Ophthalmology; 2012 May; 119(5):1056-65. PubMed ID: 22342014 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]